{"id":65036,"date":"2025-02-25T12:01:42","date_gmt":"2025-02-25T12:01:42","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/25\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/"},"modified":"2025-02-25T12:01:42","modified_gmt":"2025-02-25T12:01:42","slug":"foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/","title":{"rendered":"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p align=\"left\">CAMBRIDGE, Mass., Feb.  25, 2025  (GLOBE NEWSWIRE) &#8212; Foghorn<sup>\u00ae<\/sup> Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the B. Riley Securities Precision Oncology and Radiopharma Conference, and at the TD Cowen 45th Annual Health Care Conference. With an initial focus in oncology, Foghorn\u2019s Gene Traffic Control<sup>\u00ae<\/sup> platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.<\/p>\n<p><strong>B. Riley Securities Precision Oncology and Radiopharma Conference<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt;\">Synthetic Lethality Panel: Friday, February 28, 2025, at 9 a.m. EST in New York, NY<\/li>\n<li>Presenter: Adrian Gottschalk, President and Chief Executive Officer<\/li>\n<\/ul>\n<p><strong>TD Cowen 45th Annual Health Care Conference <\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt;\">Presentation: Monday, March 3, 2025, at 2:30 p.m. EST in Boston, MA<\/li>\n<li>Presenter: Adrian Gottschalk, President and Chief Executive Officer<\/li>\n<li>Please find a link to the webcast <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QcEubrZeFaYEvumiCHG3wbG7Wi5koMHhMUAbXqXTbiptkCfW1BrWKKTGfbYJmC5au629Vcmca0FJA8Vb_MXH4jlIO73IOKeCYhiJGY4Z7FE=\" rel=\"nofollow\" target=\"_blank\" title=\"here\">here<\/a><\/li>\n<li>Management will also participate in virtual one-on-one meetings on Monday, March 3, 2025<\/li>\n<\/ul>\n<p>A webcast of the presentation can be accessed under \u201cEvents &amp; Presentations\u201d in the Investors section of the Company\u2019s website,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SBj5gkfn5RCDzGTuZr-nKXRgfnwysuXjaSwQihC6Gv-6gNFGEaGaSS9LzvpReTXPMQiNVdwnZkVMqC0fQdArGfL9sfcXbiWZZB_f4talm3AUYn78dyGHLnazxyEqG5nLtdL0n-BunoJafbbaxzYM6YZjgpdmFkrAdMZZdgRjuVfj9AHRnu31onflWzTDoVKwpJTH0uPbdqRK0CKFqQVx2sjc1UIClHnCVT7M1tEUSeQV5Fjk9j3Pni2J5ICV86eT\" rel=\"nofollow\" target=\"_blank\" title=\"www.foghorntx.com\">www.foghorntx.com<\/a>, and will be available for 90 days.<\/p>\n<p align=\"justify\"><strong>About Foghorn Therapeutics<\/strong><br \/>Foghorn<sup>\u00ae<\/sup> Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control<sup>\u00ae<\/sup> platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is developing multiple product candidates in oncology. Visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SBj5gkfn5RCDzGTuZr-nKVLt3Fu5G23rdzluCqJghtIbBQOkHQG3RgfxQhkPTQvzAJR_vJrkEBtdwbe5zDGYbF6w4zyEO8W3nD0DLwvfmpw=\" rel=\"nofollow\" target=\"_blank\" title=\"www.foghorntx.com\">www.foghorntx.com<\/a> for more information on the Company, and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ym7A51yS3X1HAfFyyI2PJUXOk8t8K4PwaMYMuHrQ5PeXwHWVuC7a_Xnu6U2AahCTV2J9W4-ytWMfOsjjKYrZcA==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a> (formerly Twitter) and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qWB3dOArTLPlHmBV7r4enbiXUB6X_I7eaQbFFaqmwNl_0uNMU-OjCkPRsdAEvnjyF2AHDqYn_CIp0C_ARXHBV-S6Kak769bcmWvUMHt7c_a_Sv18IZWHak5DgCA-x6Ug\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p><strong>Contact:<\/strong><br \/>Karin Hellsvik, Foghorn Therapeutics Inc. <br \/><u>khellsvik@foghorntx.com<\/u><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTNlZjFlZTMtNzU2My00YWUxLWEwY2MtODNlMzgwZDc4MzQzLTEyMTQ0MTU=\/tiny\/Foghorn-Therapeutics-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the B. Riley Securities Precision Oncology and Radiopharma Conference, and at the TD Cowen 45th Annual [&#8230;]\n","protected":false},"author":1,"featured_media":65037,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-65036","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T12:01:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Foghorn-Therapeutics-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences\",\"datePublished\":\"2025-02-25T12:01:42+00:00\",\"dateModified\":\"2025-02-25T12:01:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/\"},\"wordCount\":286,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/\",\"name\":\"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-25T12:01:42+00:00\",\"dateModified\":\"2025-02-25T12:01:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences","og_description":"CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering","og_url":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-25T12:01:42+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Foghorn-Therapeutics-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences","datePublished":"2025-02-25T12:01:42+00:00","dateModified":"2025-02-25T12:01:42+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/"},"wordCount":286,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/","name":"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-25T12:01:42+00:00","dateModified":"2025-02-25T12:01:42+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/foghorn-therapeutics-to-participate-in-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=65036"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/65036\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/65037"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=65036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=65036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=65036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}